DE69228881D1 - CYCLIC CONNECTIONS FOR USE AS INHIBITORS OF GLYCOPROTEIN IIB / IIIA - Google Patents

CYCLIC CONNECTIONS FOR USE AS INHIBITORS OF GLYCOPROTEIN IIB / IIIA

Info

Publication number
DE69228881D1
DE69228881D1 DE69228881T DE69228881T DE69228881D1 DE 69228881 D1 DE69228881 D1 DE 69228881D1 DE 69228881 T DE69228881 T DE 69228881T DE 69228881 T DE69228881 T DE 69228881T DE 69228881 D1 DE69228881 D1 DE 69228881D1
Authority
DE
Germany
Prior art keywords
iiia
glycoprotein iib
inhibitors
cyclic connections
cyclic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69228881T
Other languages
German (de)
Other versions
DE69228881T2 (en
Inventor
William Degrado
Sharon Jackson
Shaker Mousa
Anju Parthasarathy
Michael Sworin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Pharma Co
Original Assignee
DuPont Merck Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DuPont Merck Pharmaceutical Co filed Critical DuPont Merck Pharmaceutical Co
Application granted granted Critical
Publication of DE69228881D1 publication Critical patent/DE69228881D1/en
Publication of DE69228881T2 publication Critical patent/DE69228881T2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

This invention relates to novel cyclic compounds containing carbocyclic ring systems useful as antagonists of the platelet glycoprotein IIb/IIIa complex, to pharmaceutical compositions containing such cyclic compounds, and to methods of using these compounds for the inhibition of platelet aggregation.
DE69228881T 1991-09-30 1992-09-30 CYCLIC CONNECTIONS FOR USE AS INHIBITORS OF GLYCOPROTEIN IIB / IIIA Expired - Fee Related DE69228881T2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US76784891A 1991-09-30 1991-09-30
US94928592A 1992-09-09 1992-09-09
PCT/US1992/008144 WO1993007170A1 (en) 1991-09-30 1992-09-30 CYCLIC COMPOUNDS USEFUL AS INHIBITORS OF PLATELET GLYCOPROTEIN IIb/IIIa

Publications (2)

Publication Number Publication Date
DE69228881D1 true DE69228881D1 (en) 1999-05-12
DE69228881T2 DE69228881T2 (en) 1999-10-14

Family

ID=27117970

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69228881T Expired - Fee Related DE69228881T2 (en) 1991-09-30 1992-09-30 CYCLIC CONNECTIONS FOR USE AS INHIBITORS OF GLYCOPROTEIN IIB / IIIA

Country Status (15)

Country Link
EP (1) EP0625164B1 (en)
JP (1) JPH07502023A (en)
AT (1) ATE178614T1 (en)
AU (1) AU672178B2 (en)
CA (1) CA2120362A1 (en)
DE (1) DE69228881T2 (en)
DK (1) DK0625164T3 (en)
ES (1) ES2131533T3 (en)
FI (1) FI941457A (en)
GR (1) GR3029931T3 (en)
HU (1) HUT68094A (en)
IL (1) IL103252A (en)
MX (1) MX9205574A (en)
NZ (1) NZ244528A (en)
WO (1) WO1993007170A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5635477A (en) * 1991-09-30 1997-06-03 The Dupont Merck Pharmaceutical Company Cyclic compounds useful as inhibitors of platelet glycoprotein IIB/IIIA
US5968476A (en) * 1992-05-21 1999-10-19 Diatide, Inc. Technetium-99m labeled peptides for thrombus imaging
CA2148945A1 (en) * 1992-11-18 1994-05-26 Gregory James Wells Cyclic compounds linked by a heterocyclic ring useful as inhibitors of platelet glycoprotein iib/iiia
HUT72896A (en) * 1993-03-29 1996-06-28 Du Pont Merck Pharma Cyclic compounds useful as inhibitors of platelet glycoprotein iib/iiia
ATE174036T1 (en) * 1993-03-29 1998-12-15 Du Pont Merck Pharma PROCESS AND INTERMEDIATE COMPOUNDS FOR PRODUCING PLATES GLYCOPROTEIN IIB/IIIA INHIBITORS
US5879657A (en) * 1993-03-30 1999-03-09 The Dupont Merck Pharmaceutical Company Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders
NZ266055A (en) * 1993-05-13 1997-02-24 Du Pont Merck Pharma Preparation of cyclic pentamide platelet glycoprotein iib/iiia inhibitors using novel intermediates
AU1975695A (en) * 1994-03-04 1995-09-18 Du Pont Merck Pharmaceutical Company, The Novel carbocyclic compounds which inhibit platelet aggregation by interaction with the gpiib/iiia receptor complex
DE4415310A1 (en) * 1994-04-30 1995-11-02 Merck Patent Gmbh Cyclopeptides
US5879659A (en) * 1996-03-13 1999-03-09 Dupont Pharmaceuticals Company Ternary radiopharmaceutical complexes
GB0623607D0 (en) 2006-11-27 2007-01-03 Haemostatix Ltd Tissue adhesive
PL2118123T3 (en) 2007-01-31 2016-06-30 Dana Farber Cancer Inst Inc Stabilized p53 peptides and uses thereof
CA2682174C (en) 2007-03-28 2021-04-06 President And Fellows Of Harvard College Stitched polypeptides
KR20130099938A (en) 2010-08-13 2013-09-06 에일러론 테라퓨틱스 인코포레이티드 Peptidomimetic macrocycles
CN108929375A (en) 2011-10-18 2018-12-04 爱勒让治疗公司 Peptidomimetic macrocyclic compound
ES2817877T3 (en) 2012-02-15 2021-04-08 Aileron Therapeutics Inc Peptidomimetic macrocycles
CA2864120A1 (en) 2012-02-15 2013-08-22 Aileron Therapeutics, Inc. Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
AU2013337388B2 (en) 2012-11-01 2018-08-02 Aileron Therapeutics, Inc. Disubstituted amino acids and methods of preparation and use thereof
JP2017533889A (en) 2014-09-24 2017-11-16 エルロン・セラピューティクス・インコーポレイテッドＡｉｌｅｒｏｎ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． Peptidomimetic macrocycles and uses thereof
CN107106642B (en) 2014-09-24 2021-02-26 艾瑞朗医疗公司 Peptidomimetic macrocycles and formulations thereof
WO2016154058A1 (en) 2015-03-20 2016-09-29 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and uses thereof
EP3347372A4 (en) 2015-09-10 2019-09-04 Aileron Therapeutics, Inc. Peptidomimetic macrocycles as modulators of mcl-1

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4857508A (en) 1987-12-03 1989-08-15 Monsanto Company Novel platelet-aggregation inhibitor peptide derivatives
AU3040589A (en) 1988-02-22 1989-09-06 Upjohn Company, The Homoarginine-based peptides as platelet aggregation inhibitors
ZW6189A1 (en) 1988-05-09 1990-05-09 Smithkline Beckman Corp Anti-aggregatory peptides
FR2631626B1 (en) 1988-05-20 1990-08-10 Centre Nat Rech Scient NOVEL PENTAPEPTIDES AND THEIR APPLICATIONS AS MEDICAMENTS, ESPECIALLY ANTITHROMBOTICS
JP2945680B2 (en) 1988-09-09 1999-09-06 旭硝子株式会社 Peptide derivatives and their uses
US5084466A (en) 1989-01-31 1992-01-28 Hoffmann-La Roche Inc. Novel carboxamide pyridine compounds which have useful pharmaceutical utility
US5120859A (en) 1989-09-22 1992-06-09 Genentech, Inc. Chimeric amino acid analogues
US4952562A (en) 1989-09-29 1990-08-28 Rorer Pharmaceutical Corporation Anti-thrombotic peptides and pseudopeptides
NZ235564A (en) 1989-10-13 1993-10-26 Merck & Co Inc Fibrinogen receptor antagonist and pharmaceutical compositions
NZ235563A (en) 1989-10-13 1993-04-28 Merck & Co Inc Fibrinogen receptor antagonist and pharmaceutical composition
AU6470590A (en) 1989-10-23 1991-04-26 Smithkline Beecham Corporation Cyclic anti-aggregatory peptides

Also Published As

Publication number Publication date
EP0625164A1 (en) 1994-11-23
NZ244528A (en) 1995-02-24
AU672178B2 (en) 1996-09-26
ATE178614T1 (en) 1999-04-15
EP0625164B1 (en) 1999-04-07
FI941457A0 (en) 1994-03-29
JPH07502023A (en) 1995-03-02
HU9400912D0 (en) 1994-06-28
MX9205574A (en) 1993-03-01
IL103252A0 (en) 1993-02-21
CA2120362A1 (en) 1993-04-15
DE69228881T2 (en) 1999-10-14
HUT68094A (en) 1995-05-29
AU2756192A (en) 1993-05-03
ES2131533T3 (en) 1999-08-01
WO1993007170A1 (en) 1993-04-15
FI941457A (en) 1994-03-29
DK0625164T3 (en) 1999-10-18
GR3029931T3 (en) 1999-07-30
IL103252A (en) 1997-03-18

Similar Documents

Publication Publication Date Title
DE69228881D1 (en) CYCLIC CONNECTIONS FOR USE AS INHIBITORS OF GLYCOPROTEIN IIB / IIIA
ATE274499T1 (en) SPIRO COMPOUNDS AS INHIBITORS OF FIBRINOGEN-DEPENDENT PLATELE AGGREGATION
ATE267200T1 (en) BICYCLIC KINASE INHIBITORS
DE69329383D1 (en) Halichondrine and related compounds
DK0578774T3 (en) Monoclonal antibodies against stem cell factor receptors
IL118262A0 (en) Isoxazolines and pharmaceutical compositions containing them
ATE282025T1 (en) INHIBITORS OF C-AMP PHOSPHODIESTERASE
ATE230398T1 (en) SUBSTITUTED HETEROCYCLIC DERIVATIVES USABLE AS PLATELE AGGREGATION INHIBITORS
FI954556A0 (en) Cyclic compounds useful as inhibitors of platelet glycoprotein IIb / IIIa
DE3650647D1 (en) Medicines used to treat anxiety
ES2074981T3 (en) USE OF HETERO CYCLIC DERIVATIVES IN THE TREATMENT OF COGNOSCITIVE DISORDERS.
DE69411584D1 (en) ISOXAZOLINE DERIVATIVES APPLICABLE AS FIBRINOGEN RECEPTOR ANTAGONISTS
EA199800534A1 (en) APPLICATION OF 2-ETHYLHEXYL-α-CYANO-β, β-DIPHENYLACRIATE
ATE187956T1 (en) SUBSTITUTED CONDENSED AND BRIDGED BICYCLIC COMPOUNDS AS THERAPEUTIC AGENTS
DK0552765T3 (en) benzimidazoles, pharmaceutical compositions containing them and processes for their preparation
BR9813281A (en) 4,5-diaryloxazole compounds, processes for their preparation, pharmaceutical composition containing the same, and their use
DE69415001T2 (en) PROCESS AND INTERMEDIATE CONNECTIONS FOR THE PRODUCTION OF GLYCOPROTEIN IIB / IIIA BLOCKERS
ATE242253T1 (en) COMPOUNDS USABLE AS ANTIPROLIFERANTS AND GAFT INHIBITORS
EA199901049A2 (en) Spiro imidazoline compounds, a process for their preparation and pharmaceutical composition containing them

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: DUPONT PHARMACEUTICALS COMPANY, WILMINGTON, DEL.,

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee